Greenberg B - Search Results

1

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

Bennett JL, de Seze J, Lana-Peixoto M, Palace J, Waldman A, Schippling S, Tenembaum S, Banwell B, Greenberg B, Levy M, Fujihara K, Chan KH, Kim HJ, Asgari N, Sato DK, Saiz A, Wuerfel J, Zimmermann H, Green A, Villoslada P, Paul F; GJCF-ICC&BR. Bennett JL, et al. Among authors: greenberg b. Mult Scler. 2015 May;21(6):678-88. doi: 10.1177/1352458514567216. Epub 2015 Feb 6. Mult Scler. 2015. PMID: 25662342 Free PMC article. Review.

2

Future research directions in multiple sclerosis therapies.

Greenberg BM, Calabresi PA. Greenberg BM, et al. Semin Neurol. 2008 Feb;28(1):121-7. doi: 10.1055/s-2007-1019133. Semin Neurol. 2008. PMID: 18256992 Review.

3

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.

Hiremath GS, Cettomai D, Baynes M, Ratchford JN, Newsome S, Harrison D, Kerr D, Greenberg BM, Calabresi PA. Hiremath GS, et al. Among authors: greenberg bm. Mult Scler. 2009 Jun;15(6):735-40. doi: 10.1177/1352458509102844. Epub 2009 Apr 21. Mult Scler. 2009. PMID: 19383644

4

Low serum vitamin D levels and recurrent inflammatory spinal cord disease.

Mealy MA, Newsome S, Greenberg BM, Wingerchuk D, Calabresi P, Levy M. Mealy MA, et al. Arch Neurol. 2012 Mar;69(3):352-6. doi: 10.1001/archneurol.2011.1974. Epub 2011 Nov 14. Arch Neurol. 2012. PMID: 22083799

5

Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success.

Greenberg BM, Graves D, Remington G, Hardeman P, Mann M, Karandikar N, Stuve O, Monson N, Frohman E. Greenberg BM, et al. Mult Scler. 2012 Jul;18(7):1022-6. doi: 10.1177/1352458511432896. Epub 2012 Jan 19. Mult Scler. 2012. PMID: 22261118

6

Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.

Mealy MA, Wingerchuk DM, Greenberg BM, Levy M. Mealy MA, et al. Arch Neurol. 2012 Sep;69(9):1176-80. doi: 10.1001/archneurol.2012.314. Arch Neurol. 2012. PMID: 22733096

7

Human aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with neuromyelitis optica.

Arellano B, Hussain R, Zacharias T, Yoon J, David C, Zein S, Steinman L, Forsthuber T, Greenberg BM, Lambracht-Washington D, Ritchie AM, Bennett JL, Stüve O. Arellano B, et al. Among authors: greenberg bm. Arch Neurol. 2012 Sep;69(9):1125-31. doi: 10.1001/archneurol.2012.1300. Arch Neurol. 2012. PMID: 22751865 Free PMC article.

8

Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS.

Frohman AR, Schnurman Z, Conger A, Conger D, Beh S, Greenberg B, Sutter E, Calabresi PA, Balcer LJ, Frohman TC, Frohman EM. Frohman AR, et al. Among authors: greenberg b. Neurology. 2012 Aug 21;79(8):797-801. doi: 10.1212/WNL.0b013e3182661edc. Epub 2012 Jul 18. Neurology. 2012. PMID: 22815550 Free PMC article.

9

Objective characterization of the relative afferent pupillary defect in MS.

Blazek P, Davis SL, Greenberg BM, Conger A, Conger D, Vernino S, Beh S, Stuve O, Saidha S, Ratchford JN, Green A, Calabresi PA, Balcer LJ, Frohman TC, Frohman EM. Blazek P, et al. J Neurol Sci. 2012 Dec 15;323(1-2):193-200. doi: 10.1016/j.jns.2012.09.015. Epub 2012 Sep 29. J Neurol Sci. 2012. PMID: 23026533

10

What is the true clinicopathologic spectrum of neuromyelitis optica?-Reply.

Greenberg BM, Wingerchuk D, Mealy M, Levy M. Greenberg BM, et al. JAMA Neurol. 2013 Feb;70(2):272-3. doi: 10.1001/jamaneurol.2013.1286. JAMA Neurol. 2013. PMID: 23400728 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,593 results

Search Page